Zhejiang Shengda Bio-Pharm News

Response to the Inquiry Letter Regarding Abnormal Fluctuations in the Trading of Zhejiang Shengda Bio-Pharmaceutical Co., Ltd. Stock.

Jul 3 12:00 ET

Zhejiang Shengda Bio-pharmaceutical Co., Ltd. announced abnormal fluctuations in stock trading.

Jul 3 12:00 ET

Legal opinion from Zhejiang Tiance Law Firm regarding differentiation dividend matters for Zhejiang Shengda Bio-pharmaceutical Co., Ltd. in 2023.

Jun 3 12:00 ET

The issuer's financial report for the most recent year and its audit report and the most recent financial report

May 21 12:00 ET

An indicative announcement by Zhejiang Shengda Biopharmaceutical Co., Ltd. on responding to the review inquiry letter and updating application documents such as prospectus for applying to issue shares to specific targets

May 21 12:00 ET

Instructions from Tianjian Certified Public Accountants (Special General Partnership) on financial matters in the review inquiry letter of Zhejiang Shengda Biopharmaceutical Co., Ltd. to issue shares to specific targets (revised draft) (2023 financial data update)

May 21 12:00 ET

Response to the review inquiry letter on Zhejiang Shengda Biopharmaceutical Co., Ltd.'s application documents for issuing shares to specific targets (revised draft) (2023 financial data update)

May 21 12:00 ET

Response to the second round review inquiry letter of Zhejiang Shengda Biopharmaceutical Co., Ltd. to issue stock application documents to specific targets (revised draft) (2023 financial data update)

May 21 12:00 ET

Zhejiang Shengda Biopharmaceutical Co., Ltd. Stock Trading Abnormal Fluctuation Notice

May 5 12:00 ET

Response to the “Zhejiang Shengda Biopharmaceutical Co., Ltd. Stock Trading Abnormal Fluctuations Inquiry Letter”

May 5 12:00 ET

Announcement of Zhejiang Shengda Biopharmaceutical Co., Ltd. on holding a performance briefing for the first quarter of 2023 and 2024

Apr 26 12:00 ET

Zhejiang Shengda Biopharmaceutical Co., Ltd. 2023 Audit Report

Apr 19 12:00 ET

Independent Director's 2023 Debriefing Report (Chen Xiqin)

Apr 19 12:00 ET

Zhejiang Shengda Biopharmaceutical Co., Ltd. 2023 Internal Control Audit Report

Apr 19 12:00 ET

Special inspection opinion of Zhejiang Shengda Biopharmaceutical Co., Ltd. on the deduction of operating income

Apr 19 12:00 ET

Independent Director's 2023 Debriefing Report (Hu Guohua)

Apr 19 12:00 ET

Independent Director's 2023 Debriefing Report (Li Yongquan)

Apr 19 12:00 ET

Announcement of Resolutions of the 11th Meeting of the Fourth Board of Directors of Zhejiang Shengda Biopharmaceutical Co., Ltd.

Apr 19 12:00 ET

Special opinion of the board of directors of Zhejiang Shengda Biopharmaceutical Co., Ltd. on the self-inspection of the independence of independent directors

Apr 19 12:00 ET

Announcement of Resolutions of the 10th Meeting of the Fourth Board of Supervisors of Zhejiang Shengda Biopharmaceutical Co., Ltd.

Apr 19 12:00 ET